Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMedpal AI Regulatory News (MPAL)

Share Price Information for Medpal AI (MPAL)

Share Price is delayed by 15 minutes
Get Live Data
2.75    0.10 (3.77%)
Bid:
2.60
Ask:
2.90
Spread: 0.30 (11.538%)
Market Cap: £16.94m
MPAL Live PriceLast checked at - London Stock Exchange

Intraday Medpal AI Share Chart

Holding(s) in Company

22 Apr 2026 15:01

RNS Number : 5374B
Medpal AI PLC
22 April 2026
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

 

 

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

MEDPAL AI PLC

 

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

 

Non-UK issuer

 

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

 

An acquisition or disposal of voting rights

 

An acquisition or disposal of financial instruments

 

An event changing the breakdown of voting rights

X

 

Other (please specify) iii:

 

3. Details of person subject to the notification obligation iv

 

Name

Jason Drummond

 

City and country of registered office (if applicable)

London, United Kingdom

 

4. Full name of shareholder(s) (if different from 3.) v

 

Name

 

City and country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached vi:

22/04/2026

 

6. Date on which issuer notified (DD/MM/YYYY):

22/04/2026

 

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

 

Resulting situation on the date on which threshold was crossed or reached

27.76%

27.76%

170,000,000

 

Position of previous notification (if

applicable)

34.52%

 

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

 

 

A: Voting rights attached to shares

 

 

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

 

 

Direct

(DTR5.1)

Indirect

 (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

 

 

GB00BTRC7N37

170,000,000

27.76%

 

 

 

 

 

 

SUBTOTAL 8. A

170,000,000

27.76%

 

 

 

 

 

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

 

 

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

 

 

 

 

 

 

 

 

SUBTOTAL 8. B 1

 

 

 

 

 

 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

 

 

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

SUBTOTAL 8.B.2

 

 

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

X

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

 

Place of completion

London, United Kingdom

Date of completion

22/04/2026

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFISSIIFFIR
12
Date   Source Headline
1st Jun 20267:00 amRNSPharmacy Operational Update
29th May 20267:00 amRNSHalf-year Financial Report
20th May 20267:00 amRNSLaunch of New Health dedicated GLP/peptides brand
1st May 20261:11 pmRNSChange of Registered Office
30th Apr 20262:06 pmRNSTotal Voting Rights-replacement
30th Apr 202612:40 pmRNSTotal Voting Rights
29th Apr 20267:00 amRNSAcquisition of Remedi Pharmacy Assets
22nd Apr 20263:02 pmRNSHolding(s) in Company
22nd Apr 20263:01 pmRNSHolding(s) in Company
20th Apr 20264:19 pmRNSIssue of Fee Shares
17th Apr 20267:00 amRNSPlacing to raise £3m
8th Apr 202612:35 pmRNS-RUpdated Research Note
8th Apr 20267:00 amRNSLaunch of MedPal Health OS
7th Apr 20267:00 amRNSPharmacy Operational Update
31st Mar 20269:00 amRNSTotal Voting Rights
25th Mar 202610:02 amRNSResult of WRAP Retail Offer
20th Mar 20265:10 pmRNSWRAP Retail Offer
20th Mar 20264:38 pmRNSPlacing and WRAP Retail Offer
20th Mar 20268:00 amRNSMedPal Enters At-Home Blood Testing Market
16th Mar 20269:36 amRNSPharmacy Operational Update
16th Mar 20269:36 amRNSPharmacy Operational Update
9th Mar 20268:02 amRNSNotice of AGM and Board Changes
27th Feb 20264:32 pmRNSFinal Results
27th Feb 20269:00 amRNSTotal Voting Rights
25th Feb 20264:34 pmRNSUpdate and close of ATM
16th Feb 20267:00 amRNSCompletion of Acquisition
12th Feb 202610:29 amRNSResult of ATM - replacement
11th Feb 20265:29 pmRNSUpdate on ATM Facility
10th Feb 20267:00 amRNSVertically Integrated Healthcare Model
5th Feb 20267:00 amRNSPharmacy operations update
3rd Feb 20262:24 pmRNSSecondary Listing on Frankfurt Exchange
30th Jan 202611:00 amRNSTotal Voting Rights
28th Jan 20267:00 amRNSEli Lilly Supply Agreement
26th Jan 20263:59 pmRNSResult of ATM
22nd Jan 20267:00 amRNSOperational Efficiency Gains in Pharmacy
16th Jan 202611:53 amRNSUpdate on ATM Facility
8th Jan 20267:00 amRNSMedPal App: AI Integration with MedPal Clinic
5th Jan 202610:20 amRNSTrading Update
16th Dec 20257:00 amRNSUpdate on ATM Facility
9th Dec 20258:00 amRNS-RCEO Interview on Vox Markets
8th Dec 20257:00 amRNSApp Update and Rollout to Epassi UK Gym Network
4th Dec 20257:00 amRNSTrading Update and At The Market Facility
10th Nov 20257:00 amRNSNHS Approval & Operational Update
7th Nov 20257:00 amRNSLaunch of MedPal Clinic Pharmacy Platform
3rd Nov 20257:00 amRNS-RInitiation of research
22nd Oct 20257:00 amRNSOpening of AI-powered National Distribution Centre
2nd Oct 20258:03 amRNSResult of WRAP Retail Offer
1st Oct 20255:17 pmRNSLaunch of WRAP Retail Offer
1st Oct 20255:13 pmRNSPlacing to raise £400,000
1st Oct 20254:50 pmRNSAcquisition of assets from Universal Pharmacy Ltd
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.